Not applicableUnknownNCT01329471What this trial is testingFunctional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Hillel Yaffe Medical Center 75
Large-scale testing (Phase 3)Study completedNCT00495287What this trial is testingA Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)Who this might be right forAcute Myelogenous Leukemia Northern Italy Leukemia Group 573
Testing effectiveness (Phase 2)Study completedNCT00014495What this trial is testingChemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT01564277What this trial is testingRasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+16 more Roswell Park Cancer Institute 24
Early research (Phase 1)Ended earlyNCT01300611What this trial is testingTXA127 in Enhancement of Engraftment in Adult Double Cord Blood TransplantationWho this might be right forDouble Cord Blood TransplantAcute Myelogenous LeukemiaMyelodysplastic Syndrome+6 more Tarix Pharmaceuticals 20
Not applicableStudy completedNCT00445744What this trial is testingCyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+19 more Fred Hutchinson Cancer Center 52
Not applicableStudy completedNCT02860793What this trial is testingRole of PTK-7 in Acute Myeloid LeukemiasWho this might be right forAcute Myeloid Leukemia Institut Paoli-Calmettes 10
Not applicableStudy completedNCT01831232What this trial is testingIdarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromesWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+16 more Fred Hutchinson Cancer Center 24
Testing effectiveness (Phase 2)WithdrawnNCT06351306What this trial is testingDEC-C and Thioguanine for R/R AMLWho this might be right forAcute Myeloid Leukemia Columbia University
Large-scale testing (Phase 3)Study completedNCT00005863What this trial is testingCombination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Medical Research Council
Testing effectiveness (Phase 2)Looking for participantsNCT06483906What this trial is testingVenetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.Who this might be right forAcute Myeloid Leukemia Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Early research (Phase 1)Ended earlyNCT03884829What this trial is testingA Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDSWho this might be right forAML, AdultMyelodysplastic SyndromesALL, Adult+2 more Cyclacel Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT00002912What this trial is testingCombination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI) 3
Early research (Phase 1)Ended earlyNCT05038800What this trial is testingEvaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)Who this might be right forRelapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Chronic Myelomonocytic Leukemia Merck Sharp & Dohme LLC 13
Testing effectiveness (Phase 2)UnknownNCT02061800What this trial is testingCD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantWho this might be right forChronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more Diane George 14
Testing effectiveness (Phase 2)Study completedNCT02395822What this trial is testingMT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML PatientsWho this might be right forAcute Myelogenous Leukemia Masonic Cancer Center, University of Minnesota 17
Large-scale testing (Phase 3)Study completedNCT02668653What this trial is testingQuizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid LeukemiaLeukemia Daiichi Sankyo 539
Not applicableLooking for participantsNCT07254312What this trial is testingCorrelation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.Who this might be right forAML (Acute Myelogenous Leukemia Fondazione IRCCS Policlinico San Matteo di Pavia 14
Testing effectiveness (Phase 2)WithdrawnNCT00967512What this trial is testingAezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction CourseWho this might be right forAcute Myelogenous Leukemia Eleos, Inc.
Not applicableStudy completedNCT07379528What this trial is testingMesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the OutcomeWho this might be right forAcute Myeloid Leukaemia (AML) Fondazione IRCCS Policlinico San Matteo di Pavia 70